Edwards Lifesciences's total assets for Q1 2026 were $13.32B, a decrease of -2.75% from the previous quarter. EW total liabilities were $2.99B for the fiscal quarter, a -10.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.